Global G-Protein Coupled Receptors Industry Insights: Key Trends and Growth Estimates
Uncover key drivers, emerging technologies, and competitive movements shaping the g-protein coupled receptors market from 2026–2035 with trusted insights from The Business Research Company
Starting from its 2026 valuation, what market size is the G-Protein Coupled Receptors Market expected to reach by 2030?
The g-protein coupled receptors market has experienced robust expansion in recent years. It is anticipated to increase from $3.4 billion in 2025 to $3.63 billion in 2026, registering a compound annual growth rate (CAGR) of 6.8%. The historical growth in this market can be linked to the rise in neurotransmitter research, progress in receptor biology, the broadening of pharmaceutical R&D, advancements in cell line development, and innovations in assay technology.
The g-protein coupled receptors market is anticipated to experience significant expansion in the upcoming years, with its size projected to reach $4.77 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.0%. This projected growth during the forecast period is fueled by elements such as the rising demand for precision drug targeting, the emergence of AI-driven drug discovery, the expansion of the biologics pipeline, ongoing receptor deorphanization research, and increased investment in translational research. Prominent trends expected in this period include the escalating utilization of GPCR targets within drug discovery, the broadening of high-throughput screening capabilities, a sharpened focus on orphan receptor investigations, the advancement of cell-based assay technologies, and strengthened collaboration between academic institutions and pharmaceutical firms.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11976&type=smp
What Drivers Are Driving Adoption Within The G-Protein Coupled Receptors Market?
The anticipated expansion of the G-protein-coupled receptors market is linked to the increasing occurrence of cancer. Cancer is a medical condition characterized by the uncontrolled proliferation and invasion of aberrant cells into adjacent tissues. Furthermore, cancer cells have the potential to disseminate throughout the body via the lymphatic and vascular networks. G-protein-coupled receptors (GPCRs) regulate essential cancer-related processes such as proliferative signaling, the acquisition of replicative immortality, the ability to evade growth suppressors, resistance to programmed cell death (apoptosis), and the initiation of invasion and metastasis. For example, reports from the American Cancer Society, a professional organization located in the US, indicated that in January 2023, there were 1,958,310 new cancer diagnoses in the United States during 2023, which marked an increase compared to the approximately 1.9 million new cases estimated for 2022. Consequently, the growing incidence of cancer is a key factor propelling the expansion of the G-protein coupled receptors market.
What Segments Are Included Within The G-Protein Coupled Receptors Market?
The g-protein coupled receptors market covered in this report is segmented –
1) By Product: Cell Lines, Detection Kits, Cell Culture Reagents, Ligands
2) By Assay: CAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding And GTP?S Functional Assays, Internalization Assays, Trafficking Assays
3) By Applications: Cancer Research, CNS Research, Metabolic Research, Cardiovascular Research, Inflammation Research, Respiratory Research, Other Applications
Subsegments:
1) By Cell Lines: GPCR-Expressing Cell Lines, Stable And Transient Cell Lines
2) By Detection Kits: ELISA Kits, High-Throughput Screening Kits, Reporter Gene Assays
3) By Cell Culture Reagents: Media And Supplements, Transfection Reagents, Growth Factors
4) By Ligands: Agonists, Antagonists, Inverse Agonists
Which Trends Are Influencing The Performance And Direction Of The G-Protein Coupled Receptors Market?
Leading companies operating within the G-protein coupled receptors market are launching Initial Public Offerings (IPOs) with the objective of developing drugs that target G protein-coupled receptors (GPCRs). This strategy aims to expedite research and development, progress clinical trials, and deliver novel therapies to the market for a variety of conditions, including cancer, neurological disorders, and metabolic conditions. The funds generated are primarily intended to facilitate the development of the company’s key product candidates, which are focused on chronic metabolic and pulmonary diseases. More specifically, the proceeds are earmarked for advancing their glucagon-like peptide-1 receptor (GLP-1R) agonist program, which focuses on treatments for diabetes and obesity. For instance, in February 2023, Structure Therapeutics Inc, a US-based company, concluded its initial public offering (IPO), raising $161 million to further its development of G-protein coupled receptor (GPCR)-based therapeutics. The company offered 10,740,000 American depositary shares (ADSs) for $15.00 per ADS, a value that significantly surpassed its initial projections. The shares commenced trading on the Nasdaq Global Market using the ticker symbol ‘GPCR’.
Who Are The Major Companies Operating In The G-Protein Coupled Receptors Market?
Major companies operating in the g-protein coupled receptors market are Pfizer Inc., Roche Holding AG, AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck KGaA, Boehringer Ingelheim, Daiichi Sankyo Company Limited, Danaher Corporation, Thermo Fisher Scientific Inc., PerkinElmer Inc., Bio-Techne Corporation, Abcam PLC, Cara Therapeutics Inc., Sosei Heptares Ltd., Eurofins DiscoverX Corporation, Crinetics Pharmaceuticals Inc., Domain Therapeutics SA, Addex Pharmaceuticals Ltd., Structure Therapeutics, Septerna
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/g-protein-coupled-receptors-global-market-report
Which Region Is Anticipated To See The Fastest Growth In The G-Protein Coupled Receptors Market?
North America was the largest region in the G-protein coupled receptors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the g-protein coupled receptors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized G-Protein Coupled Receptors Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=11976&type=smp
Browse Through More Reports Similar to the Global G-Protein Coupled Receptors Market 2026, By The Business Research Company
Muscarinic Acetylcholine Receptor Market Report 2026
Glp 1 Receptor Agonist Market Report 2026
https://www.thebusinessresearchcompany.com/report/glp-1-receptor-agonist-global-market-report
Glucagon Like Peptide 1 Market Report 2026
https://www.thebusinessresearchcompany.com/report/glucagon-like-peptide-1-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
